Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

(NQ: )

N/A UNCHANGED
Last Price Updated: Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about

< Previous 1 2 Next >
Avalanche Biotechnologies Closes Transaction With Annapurna Therapeutics and Changes Name to Adverum Biotechnologies
Avalanche Biotechnologies, Inc. (Nasdaq:AAVL) today announced the closing of the previously announced transaction with Annapurna Therapeutics. The combined company has been renamed Adverum... 
From GlobeNewswire News Releases
Avalanche Biotechnologies’ Stockholders Vote in Favor of Annapurna Transaction
Avalanche Biotechnologies, Inc. (Nasdaq:AAVL) today announced that its stockholders, at its annual meeting held today, approved the issuance of shares of the Company’s common stock to the shareholders... 
From GlobeNewswire News Releases
Avalanche Biotechnologies, Inc. Reports First Quarter 2016 Financial Results
Avalanche Biotechnologies, Inc. (Nasdaq:AAVL), a gene therapy company committed to discovering and developing novel medicines for patients suffering from diseases with few or burdensome treatment... 
From GlobeNewswire News Releases
Avalanche Biotechnologies to Present at Upcoming Scientific Meetings
Avalanche Biotechnologies, Inc. (Nasdaq:AAVL), a gene therapy company committed to discovering and developing novel medicines for patients suffering from diseases with few or burdensome treatment... 
From GlobeNewswire News Releases
Science Center’s Global Soft Landing Program Grows with Addition of Companies from France and U.K.
Tags Technology: General Science: Major Verticals Business
From PRWeb
Avalanche Biotechnologies Reports Fourth Quarter and Fiscal 2015 Financial Results
Avalanche Biotechnologies, Inc. (Nasdaq:AAVL), a gene therapy company committed to discovering and developing novel medicines for patients suffering from chronic or debilitating disease, today reported... 
From GlobeNewswire News Releases
Avalanche Biotechnologies to Present at Upcoming Investor Conferences
Avalanche Biotechnologies, Inc. (Nasdaq:AAVL), a gene therapy company committed to discovering and developing novel medicines for patients with chronic or debilitating disease, today announced that... 
From GlobeNewswire News Releases
Avalanche Biotechnologies Inc (NASDAQ:AAVL) Shareholder Alert: Lawsuit in Connection with Jan. 2015 Stock Offering Filed
San Diego, CA -- (SBWIRE) -- 02/02/2016 -- A shareholder in Avalanche Biotechnologies Inc's follow-on public stock offering completed on January 13, 2015 filed a lawsuit over alleged violations of... 
From SBWire - Latest Press Releases
Avalanche Biotechnologies and Annapurna Therapeutics Announce Proposed Merger
Combined Scientific, Financial and Human Resources Will Support Robust Gene Therapy Pipeline Companies to Host Conference Call Today at 8:00 a.m. ET/ 5:00 a.m. PT 
From GlobeNewswire News Releases
INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Investing in Avalanche Biotechnologies, Inc. (AAVL) to Contact the Firm
Faruqi & Faruqi, LLP, a leading national securities law firm, has been appointed to serve as Lead Counsel in the consolidated class action captioned In re Avalanche Biotechnologies, Inc., Sec. Litig.,... 
From GlobeNewswire News Releases
INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Investing In Avalanche Biotechnologies, Inc. (AAVL) To Contact The Firm
Tags Business & Professional Services
From ACCESSWIRE
INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Investing In Avalanche Biotechnologies, Inc. (AAVL) To Contact The Firm
Faruqi & Faruqi, LLP, a leading national securities law firm, has been appointed to serve as Lead Counsel in the consolidated class action captioned In re Avalanche Biotechnologies, Inc., Sec. Litig.,... 
From PR Newswire
The Road Ahead - New Reports on NephroGenex, FairPoint Communications, Avalanche Biotechnologies and Exar
Tags Business & Professional Services
From ACCESSWIRE
Lawsuit for Investors Who Purchased Shares of Avalanche Biotechnologies Inc (NASDAQ:AAVL) in the Jan. 2015 Stock Offering Announced by Shareholders Foundation
The Shareholders Foundation, Inc. announces that a lawsuit was filed on behalf of investors who purchased shares of Avalanche Biotechnologies Inc (NASDAQ:AAVL) in Avalanche Biotechnologies’ follow-on... 
From GlobeNewswire News Releases
Avalanche Biotechnologies, Inc. Names Paul B. Cleveland as CEO
Avalanche Biotechnologies, Inc. (Nasdaq:AAVL), a biopharmaceutical company committed to improving or preserving the sight of people suffering from serious eye diseases with an unmet medical need, today... 
From GlobeNewswire News Releases
Avalanche Biotechnologies, Inc. Reports Third Quarter 2015 Financial Results
Avalanche Biotechnologies, Inc. (Nasdaq:AAVL), a biopharmaceutical company committed to improving or preserving the sight of people suffering from serious eye diseases with an unmet medical need, today... 
From GlobeNewswire News Releases
Equities Note on the Healthcare Sector -- Aegerion Pharmaceuticals, Align Technology, Avalanche Biotechnologies, Agios Pharmaceuticals and Catalyst Pharmaceutical Partners
From PR Newswire
AVALANCHE 96 HOUR DEADLINE ALERT: Approximately 96 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors of Deadline in Class Action Lawsuit Against Avalanche Bio
From Marketwired News Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Avalanche Biotechnologies, Inc. of Class Action Lawsuit and Upcoming Deadline - AAVL
From Marketwired News Releases
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess Of $100,000 Investing in Avalanche Biotechnologies, Inc. to Contact the Firm Before Imminent Lead Plaintiff D
From GlobeNewswire News Releases
SHAREHOLDER ALERT: The Law Offices of Vincent Wong Remind Investors of Class Action Involving Avalanche Biotechnologies, Inc. and a Lead Plaintiff Deadline of September 8, 2015 -- AAVL
From GlobeNewswire News Releases
AVALANCHE BIOTECHNOLOGIES, INC. SHAREHOLDER UPDATE: Kessler Topaz Meltzer & Check, LLP Announces Update to Class Action and Reminds Avalanche Biotechnologies, Inc. Shareholders of Impending Deadline -
From GlobeNewswire News Releases
Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action against Avalanche Biotechnologies, Inc. and Lead Plaintiff Deadline September 8, 2015
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a securities class action has been filed in the United States District Court for the Southern District of New York on... 
From PR Newswire
ALERT: Rosen Law Firm Reminds Avalanche Biotechnologies, Inc. Investors of Important September 8, 2015 Deadline in Class Action Lawsuit Filed by Firm -- AAVL
From GlobeNewswire News Releases
AVALANCHE SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against
Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until September 8, 2015 to file lead plaintiff... 
From PR Newswire
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Avalanche Biotechnologies, Inc. of Pendency of Class Action Lawsuit and a Lead Plaintiff Deadline of September 8, 2015 -- AAVL
From GlobeNewswire News Releases
Avalanche Biotechnologies Inc (NASDAQ:AAVL) Shareholder Notice: Investigation of Potential Wrongdoing
San Diego, CA -- (SBWIRE) -- 08/26/2015 -- An investigation on behalf of current long-term investors in shares of Avalanche Biotechnologies Inc (NASDAQ:AAVL) was announced concerning potential breaches... 
From SBWire - Latest Press Releases
AVALANCHE BIOTECHNOLOGIES, INC. SHAREHOLDER UPDATE: Kessler Topaz Meltzer & Check, LLP Announces Update to Shareholder Class Action Against Avalanche Biotechnologies, Inc. -- AAVL
From PR Newswire
AVALANCHE SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against
From GlobeNewswire News Releases
Avalanche Biotechnologies, Inc. Reports Second Quarter 2015 Financial Results and Provides Update on AVA-101 Program
From GlobeNewswire News Releases
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.